Teva Pharmaceutical Industries Ltd. will relocate or shut down most of its manufacturing operations in Israel, according to a document reviewed by Calcalist and people familiar with the matter who spoke on condition of anonymity. The company’s plans in Israel are part of the wider global restructuring strategy announced by the company late November. The company intends to implement the plan in the next few months, in the hope of presenting significant cost cuts in its earnings report for the first quarter of 2018, according to the document.
For daily updates, subscribe to our newsletter by clicking here.
Following a late-night board meeting, the company has decided to let go over half of its Israeli workforce, cutting…
Read the full article at: https://www.calcalistech.com/ctech/articles/0,7340,L-3727309,00.html